HPC — Hydration Pharmaceuticals Co Balance Sheet
0.000.00%
- AU$2.74m
- -AU$2.29m
- $3.20m
Annual balance sheet for Hydration Pharmaceuticals Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.64 | 10.7 | 4.69 | 1.84 | 3.22 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.787 | 1.01 | 1.31 | 1.75 | 0.353 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 4.44 | 15.3 | 10.4 | 6.69 | 5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.003 | 0 | — | — | — |
Other Long Term Assets | |||||
Total Assets | 4.45 | 15.3 | 10.4 | 6.69 | 5 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.42 | 2.06 | 2.68 | 3.13 | 2.23 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.44 | 2.08 | 6.41 | 7.05 | 2.25 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2 | 13.2 | 3.98 | -0.358 | 2.74 |
Total Liabilities & Shareholders' Equity | 4.45 | 15.3 | 10.4 | 6.69 | 5 |
Total Common Shares Outstanding |